Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Kruppel like factor 1 | 0.621 | 0.462 | 3.6E-04 |
|
phenotype | 0.400 | moderate | 0 | 0 | |||||||||||
|
Kruppel like factor 1 | 0.621 | 0.462 | 3.6E-04 |
|
phenotype | 0.400 | moderate | 0 | 0 | |||||||||||
|
optic atrophy 8 (autosomal dominant) | 0.839 | 0.231 |
|
disease | 0.300 | None | 0 | 0 | ||||||||||||
|
EBP cholestenol delta-isomerase | 0.494 | 0.846 | 0.94 |
|
phenotype | 0.300 | strong | 0 | 0 | |||||||||||
|
retinoic acid induced 1 | 0.545 | 0.731 | 1.00 |
|
disease | 0.300 | strong | 0 | 0 | |||||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
phenotype | 0.300 | strong | 0 | 0 | |||||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.600 | strong | 0 | 0 | |||||||||||
|
CF transmembrane conductance regulator | 0.424 | 0.885 | 2.2E-58 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
serologically defined colon cancer antigen 8 | 0.619 | 0.577 | 1.2E-11 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
complement factor H related 4 | 0.839 | 0.346 | 2.4E-18 |
|
group | 0.300 | moderate | 0 | 0 | |||||||||||
|
complement factor H related 3 | 0.663 | 0.462 | 1.7E-11 |
|
group | 0.300 | moderate | 0 | 0 | |||||||||||
|
patatin like phospholipase domain containing 6 | 0.533 | 0.769 | 1.9E-13 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
ectodysplasin A receptor | 0.623 | 0.423 | 1.3E-06 |
|
phenotype | 0.300 | strong | 0 | 0 | |||||||||||
|
AFG3 like matrix AAA peptidase subunit 2 | 0.588 | 0.462 | 5.3E-09 |
|
phenotype | 0.400 | strong | 0 | 0 | |||||||||||
|
ventral anterior homeobox 1 | 0.700 | 0.423 | 0.77 |
|
group | 0.300 | limited | 0 | 0 | |||||||||||
|
chromodomain helicase DNA binding protein 1 | 0.628 | 0.692 | 1.00 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
citron rho-interacting serine/threonine kinase | 0.555 | 0.692 | 1.00 |
|
disease | 0.300 | moderate | 0 | 0 | |||||||||||
|
elastin microfibril interfacer 1 | 0.743 | 0.269 | 4.4E-03 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
solute carrier family 7 member 9 | 0.666 | 0.692 | 9.1E-10 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
solute carrier family 7 member 9 | 0.666 | 0.692 | 9.1E-10 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
WNT inhibitory factor 1 | 0.507 | 0.731 | 1.3E-09 |
|
disease | 0.300 | limited | 0 | 0 | |||||||||||
|
A-kinase anchoring protein 10 | 0.760 | 0.308 | 0.11 |
|
group | 0.500 | None | 0 | 0 | |||||||||||
|
A-kinase anchoring protein 10 | 0.760 | 0.308 | 0.11 |
|
phenotype | 0.300 | None | 0 | 0 | |||||||||||
|
neurexophilin 2 | 0.821 | 0.154 | 0.93 |
|
disease | 0.300 | None | 0 | 0 | |||||||||||
|
intraflagellar transport 43 | 0.617 | 0.577 | 1.8E-11 |
|
disease | 0.300 | None | 0 | 0 |